Skip to content
GLP-1 Decoder

Wegovy and Insulin: Is It Safe? Label, Studies

Low blood sugar is more likely with insulin; your doctor may lower the insulin dose.

Verdict
With care, using it is fine
Label says
Listed interaction

Check a GLP-1 interaction

Wegovy in brief

How long it remains in the body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week: after 7 d, half is gone, and about 3% remains following five half-lives (35 d).

Weight loss in its main trial
Wegovy (STEP 1)14.9%Placebo2.4%

At 68 weeks in STEP 1: 14.9% of body weight, compared with 2.4% on placebo.

Costs over time
202520262027$1,349.02$0List priceSelf-pay

Monthly prices in US dollars include the list price and self-pay offers. Each figure comes from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

Wegovy and insulin: the verdict

With care, using it is fine

Wegovy label wording for the drug interactions section, word for word:

“The risk of hypoglycemia is increased when WEGOVY is used concomitantly with insulin or insulin secretagogues (e.g., sulfonylureas). The addition of WEGOVY in patients treated”

The source is the DailyMed FDA label.

What the Label says

The Wegovy label contains the relevant lines on insulin.

Drug interactions appear in the Wegovy label
Named in the labelThe riskWhat the label tells doctors
Insulin or sulfonylureasLow blood sugarLow blood sugar is more likely when it is used with insulin or a sulfonylurea. Examples include glipizide or glimepiride. Your doctor may reduce those doses.

Source: Wegovy label (DailyMed).

What the studies show

The source is the DailyMed FDA label.

The practical rule

  1. Check your blood sugar more often when you start or change doses.
  2. During the first weeks and following every dose increase, monitor your blood sugar more often.

The source is the DailyMed FDA label.

Insulin with other GLP-1s

For this issue, we reviewed the drug interaction section of each label.

Insulin across GLP-1 labels
MedicineInsulin in the labelVerdictPage
OzempicNamed in the labelWith care, using it is fineRead the answer
WegovyNamed in the labelWith care, using it is fineNot listed
RybelsusNamed in the labelNot listedNot listed
MounjaroNamed in the labelWith care, using it is fineRead the answer
ZepboundNamed in the labelWith care, using it is fineRead the answer
FoundayoNamed in the labelNot listedNot listed
TrulicityNamed in the labelWith care, using it is fineRead the answer
SaxendaNamed in the labelNot listedNot listed
VictozaNamed in the labelWith care, using it is fineRead the answer
ByettaNamed in the labelNot listedNot listed

The source is the DailyMed FDA label.